Cargando…
Inhibitory activity of apogossypol in human prostate cancer in vitro and in vivo
Apogossypol, a gossypol derivative, is a novel small-molecule inhibitor of the Bcl-2 family proteins and has been demonstrated to have anti-tumor activities. Prostate cancer is the most common malignancy in males, for which chemotherapy is the usual treatment option in clinical practice. The aim of...
Autores principales: | ZHAN, WENHUA, HU, XINGBIN, YI, JING, AN, QUNXING, HUANG, XIAOFENG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394964/ https://www.ncbi.nlm.nih.gov/pubmed/25672487 http://dx.doi.org/10.3892/mmr.2015.3326 |
Ejemplares similares
-
Inhibitory activity of apogossypol in human prostate cancer in vitro and in vivo
por: Zhan, Wenhua, et al.
Publicado: (2018) -
Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo
por: ZHANG, XIANQING, et al.
Publicado: (2014) -
Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo
por: Zhang, Xianqing, et al.
Publicado: (2018) -
Apogossypol-mediated reorganisation of the endoplasmic reticulum antagonises mitochondrial fission and apoptosis
por: Yedida, Govindaraju, et al.
Publicado: (2019) -
Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
por: Wang, Yafen, et al.
Publicado: (2022)